Quest Diagnostics Incorporated
DGX Healthcare Diagnostics & Research
Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow DGX
Quest Diagnostics Incorporated (DGX) Revenue growth
Quest Diagnostics Incorporated's revenue growth over the twelve months to 30 June 2026 was 9.87%, down 1.9 percentage points from fiscal 2025 (11.8%). Over the past ten years it has ranged from −8.39% (fiscal 2022) to 22.2% (fiscal 2020); the current reading is higher than 82% of that period. That is above the Diagnostics & Research industry median of 7.69% and above the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 11.8% | 5.08 |
| FY2024 | 6.70% | 13.08 |
| FY2023 | −6.38% | 2.01 |
| FY2022 | −8.39% | (22.71) |
| FY2021 | 14.3% | (7.83) |
| FY2020 | 22.2% | 19.56 |
| FY2019 | 2.59% | 0.85 |
| FY2018 | 1.74% | (0.87) |
| FY2017 | 2.61% | 6.33 |
| FY2016 | −3.72% | (4.50) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 10.2% | 1.05 |
| Mar 2026 | 9.16% | 2.10 |
| Dec 2025 | 7.06% | (6.12) |
| Sep 2025 | 13.2% | (2.01) |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WAT Waters Corporation compare | 52.5% |
| GH Guardant Health, Inc. compare | 42.7% |
| MEDP Medpace Holdings, Inc. compare | 24.7% |
| IDXX IDEXX Laboratories, Inc. compare | 12.8% |
| DGX Quest Diagnostics Incorporated | 9.87% |
| MTD Mettler-Toledo International, Inc. compare | 6.91% |
| LH Labcorp Holdings Inc. compare | 6.41% |
| ILMN Illumina, Inc. compare | 4.88% |
| RVTY Revvity Inc. compare | 4.05% |
| Diagnostics & Research industry median | 7.69% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on DGX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement